Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Innovent Biologics Reports 15.3% Revenue Growth in 2022 Interim Results
February 4, 2025
Company
Drug
Lepu Biotechnology’s MRG003 Receives Breakthrough Therapy Designation for Nasopharyngeal Carcinoma
February 11, 2025
Company
Drug
Lepu Biotechnology’s PD-1 Inhibitor HX008 Gains New Indication Approval
February 11, 2025
Company
Drug
Neurophth Biotechnology Doses First Patient in Phase III Trial for NR082
February 4, 2025
Company
Drug
Bio-Thera Solutions Completes Phase I Study for COVID-19 Antibody BAT2022
February 4, 2025
Company
Allergan Aesthetics Opens Shanghai Innovation Center for Medical Aesthetics
February 4, 2025
Company
Biosyngen to Establish Cell Therapy GMP Facility in Singapore
February 4, 2025
Company
Luye Pharma Reports Decline in H1 Revenue and Profits Amid Market Challenges
February 4, 2025
Company
Medical Device
Parexel Opens Clinical Study Supply Chain Center in Suzhou
February 4, 2025
Company
Drug
Abbisko Therapeutics Doses First Patient in Phase I Study of ABSK043
February 4, 2025
Company
Drug
Arctic Vision Enrolls First Patient in Phase III Study for ARVN002
February 4, 2025
Company
Deals
3D Medicines Partners with Denfo Medical for Cancer Therapy Development
February 4, 2025
1
2
3
4
…
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
